Dr Crispin Hiley
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr Crispin Hiley.png

Dr Crispin Hiley

Dr Crispin Hiley
BSc (HONS.) MBChB (HONS.) PGDIP PHD MRCP FRCR, Associate Professor and Consultant Clinical Oncologist

Languages spoken


Expert in

SBRT for all types of cancer and lung cancer



London Cromwell Hospital
London Cromwell Hospital
51.49546, -0.19115

Clinical Director for lung cancer at GenesisCare in the UK

Dr Hiley is an Associate Professor with tenure in Radiation Oncology at UCL and a Consultant Clinical Oncologist at UCLH.

Dr Hiley specialises in the use of stereotactic radiotherapy (SBRT) for oligo metastatic and oligo progressive disease for many types of cancer including but not limited to breast, prostate, colorectal, gynaecological, sarcoma and lung.

He specialises in all the non-surgical treatments for all types of lung cancer. He has expertise in chemotherapy, immunotherapy and radiotherapy including state of the art radiotherapy techniques including Volumetric Arc Therapy (VMAT), Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Proton Therapy and Stereotactic Radiotherapy (SBRT).

Her specialises in reirradiation, the use of radiotherapy for patients who have received prior radiotherapy, in the management of lung cancer and oligo metastatic and oligo progressive disease of many different cancer types.  

He graduated with honours from the University in Manchester in 2005. He has trained in Oncology at many centres of excellence both in the UK and abroad. These include the Christie Hospital, the MD Anderson Cancer Centre (Houston, USA), Kings College (NIHR Clinical Lecturer) and the Royal Marsden (NIHR Clinical Fellow). He completed a PhD at the University of London with the Barts Cancer Institute and a postdoctoral research Fellowship at the Francis Crick Institute and the UCL Cancer Institute.

He became a consultant in 2018 and is clinical lead of the clinical oncology lung team at UCLH, UCLH Lead for Lung Proton Therapy, Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence and NIHR Clinical Research Network Speciality Research Lead Radiotherapy for North London. He heads a research group at the UCL Cancer Institute focused on understanding resistance to radiation therapy.

He is the principal investigator and national chief investigator for a number of academic and commercial clinical trials in lung cancer. He has published in a number of the world’s leading journals including NEJM, The Lancet, Nature and Cell. He is a member of the expert group which authored the Radiotherapy for Lung Cancer Royal College of Radiologists Consensus Statement.

Career positions

Current position(s)

  • Consultant Clinical Oncologist, UCLH and Associate Professor, UCL



  • University in Manchester 
  • PhD at the University of London with the Barts Cancer Institute
  • Postdoctoral research Fellowship at the Francis Crick Institute and the UCL Cancer institute

Expertise and interests


  • Lung cancer


  • Management of locally advanced lung cancer.
  • Role of radiotherapy in mesothelioma.
  • Immunotherapy for non-small cell lung cancer
  • SABR for oligometastatic disease
  • Proton therapy for lung cancers
  • Understanding resistance to radiotherapy and immunotherapy in NSCLC.
  • Proton therapy

Professional memberships

  • ASCO
  • ESMO
  • RCR
  • Co-Lead, Genomics England Clinical Interpretations Partnership for Lung Cancer
  • Deputy Chair, National Cancer Research Institute Lung Group
  • Speciality Research Lead for Radiotherapy, NIHR Clinical Research Network (North Thames Region)
  • Fellow, Royal College of Radiologists
  • Member, Royal College of Physicians



  • Francis Crick Translation Fellow
  • Royal College of Radiologist Ross Award
  • The Wolfson Foundation Scholarship
  • Dreschfield Memorial Scholarship


Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

Our team will aim to respond to your enquiry as quickly as possible. If you have a medical emergency, please dial 999.

* Indicates a required field.